Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus

Brain Research

Volumn 770, Issue 1-2, 1997, Pages 45-52

  Tashiro, Yuzuru ^a   Drake, James M ^a   Chakrabortty, Shushovan ^a   Hattori, Toshiaki ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acetylcholine; Basal ganglia; Dopamine; GABA; Immunohistochemistry; Kaolin induced hydrocephalus; Mechanical distortion

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN INJURY; CHOLINERGIC NERVE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HYDROCEPHALUS; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; AGE FACTORS; ANIMALS; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; KAOLIN; MALE; MESENCEPHALON; MOVEMENT DISORDERS; NEOSTRIATUM; NEURONS; NISSL BODIES; PHARMACEUTIC AIDS; RATS; RATS, WISTAR; STAINING AND LABELING; STRESS, MECHANICAL; TYROSINE 3-MONOOXYGENASE;

EID: 0030779619     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00742-7     Document Type: Article

References (47)

1. Berger L., Gauthier S., Leblanc R. Akinetic mutism and parkinsonism associated with obstructive hydrocephalus. Can. J. Neurol. Sci. 12:1985;255-258.
2. Bolam J.P., Inghan C.A., Smith A.D. The section-Golgi-impregnation procedure. 3. Combination of Golgi-impregnation with enzyme histochemistry and electron microscopy to characterize acetylcholinesterase-containing neurons in the rat neostriatum Neuroscience. 12:1984;687-709.
3. Brazin M.E., Epstein L.G. Reversible parkinsonism from shunt failure. Pediatr. Neurol. 1:1985;306-307.
4. G.D. Chiara, M. Morelli, Dopamine-acetylcholine-glutamate interactions in the striatum: a working hypothesis, in: H. Narabayashi, T. Nagatsu, N. Yanagisawa, Y. Mizuno (Eds.), Advances in Neurology, vol. 60, Raven Press, New York, 1993, pp. 102-106.
5. Chovanes G.I., McAllister J.P. II, Lamperti A.A., Salotto A.G., Truex R.C. Jr. Monoamine alterations during experimental hydrocephalus in neonatal rats. Neurosurgery. 22:1988;86-91.
6. Chumas P.D., Drake J.M., Del Bigio M.R., Da Silva M., Tuor U.I. Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. J. Neurosurg. 80:1994;491-501.
7. Da Silva M.C., Drake J.M., Lemaire C., Cross A., Tuor U.I. High-energy phosphate metabolism in a neonatal model of hydrocephalus before and after shunting. J. Neurosurg. 81:1994;544-553.
8. Da Silva M.C., Michowicz S., Drake J.M., Chumas P.D., Tuor U.I. Reduced local cerebral blood flow in periventricular white matter in experimental neonatal hydrocephalus - restoration with CSF shunting. J. Cereb. Blood Flow Metab. 15:1995;1057-1065.
9. Del Bigio M.R., Bruni J.E. Changes in periventricular vasculare of rabbit brain following induction of hydrocephalus and after shunting. J. Neurosurg. 69:1988;115-120.
10. Del Bigio M.R., Bruni J.E. Silicone oil-induced hydrocephalus in the rabbit. Child's Nerv. Syst. 7:1991;79-84.
11. Drake J.M., Potts D.G., Lemaire C. Magnetic resonance imaging of silastic-induced canine hydrocephalus. Surg. Neurol. 31:1989;28-40.
12. Edvinsson L., Nielsen K.C., Owman C., Rosengren E., West K.A. Concomitant fall in brain dopamine and homovanillic acid in hydrocephalic rabbits. Exp. Neurol. 37:1972;647-649.
13. Ehara K., Matsumoto S., Yoshida N., Kuno T., Tanaka C. Ascending norepinephrine pathways impaired in experimental hydrocephalus. Jpn. J. Pharmacol. 32:1982;205-208.
14. Ehringer H., Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien. Klin. Wschr. 38:1960;1236-1239.
15. J.H. Fallon, S.E. Loughlin, Substantia nigra, in: G. Paxinos (Ed.), The Rat Nervous System, vol. 1, Forebrain and midbrain, Academic Press, Sidney, 1985, pp. 353-374.
16. K. Fleischhauer, Ependyma and subependymal layer, in: G.H. Bourne (Ed.), The Structure and Function of Nervous Tissue, Academic Press, New York, 1972, pp. 1-46.
17. Freund T.F., Buzsaki G., Leon A., Baimbridge K.G., Somogyi P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Exp. Brain Res. 83:1990;55-66.
18. Gatto M., Micheli F., Pardal M.F. Blepharoclonus and parkinsonism associated with aqueductal stenosis. Movement Disorders. 5:1990;310-313.
19. Groves P.M. A theory of the functional organization of the neostriatum and the nigrostriatal control of voluntary movement. Brain Res. 5:1983;109-132.
20. Hale P.M., McAllister J.P. II, Katz S.D., Wright L.C., Lovely T.J., Miller D.W., Wolfson B.J., Salotto A.G., Shroff D.V. Improvement of cortical morphology in infantile hydrocephalic animals after ventriculoperitoneal shunt placement. Neurosurgery. 31:1992;1085-1096.
21. Hassler R. Striatal control of locomotion, intentional actions, and integrating and perceptive activity. J. Neurol. Sci. 36:1978;187-224.
22. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18:1966;925-964.
23. Kemp J.M., Powell T.P.S. The structure of the caudate nucleus of the cat: light and electron microscopy. Phil. Trans. B. 262:1971;383-401.
24. Kita H., Kitai S.T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447:1988;346-352.
25. S.T. Kitai, R.J. Preston, G.A. Bishop, J.D. Kocsis, Striatal projection neurons: morphological and electrophysiological studies, in: L.J. Poirier, T.L. Sourkes, P.J. Bedard (Eds.), Advances in Neurology, vol. 24, Raven Press, New York, 1979, pp. 45-51.
26. Kosaka T., Tauchi M., Dahl J.L. Cholinergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp. Brain Res. 70:1988;605-617.
27. Kubota Y., Inagaki S., Shimada S., Kito S., Eckenstein F., Tohyama M. Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons. Brain Res. 413:1987;179-184.
28. Kuchiwaki H., Nagasaka M., Inao S., Sugita K. Progression of kaolin-induced hydrocephalus and changes in performance of operant tasks by rats. J. Neurol. Sci. 121:1994;32-38.
29. Lindvall O., Bjorklund A. The organization of ascending catecholamine neuron systems in the rat brain. Acta. Physiol. Scand. 412:1974;3-48.
30. Lovely T.J., McAllister J.P. II, Miller D.W., Lamperti A.A., Wolfson B.J. Effects of hydrocephalus and surgical decompression on cortical norepinephrine levels in neonatal cats. Neurosurgery. 24:1989;43-52.
31. Marsden C.D. Functions of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease. Can. J. Neurol. Sci. 11:1984;129-135.
32. McAllister J.P. II, Cohen M.I., O'Mara K.A., Johnson M.H. Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts: an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery. 29:1991;329-340.
33. Miodrag A., Das T.K., Shepherd R.J. Normal pressure hydrocephalus presenting as Parkinson's syndrome. Postgrad. Med. J. 63:1987;113-115.
34. Miwa S., Inagaki C., Fujiwara M., Takaori S. The activities of noradrenergic and dopaminergic neuron systems in experimental hydrocephalus. J. Neurosurg. 57:1982;67-73.
35. Paine R.S. Hydrocephalus. Pediatr. Clin. N. Am. 14:1967;779-796.
36. 14C]-deoxyglucose into brain of young rats with inherited hydrocephalus. Exp. Neurol. 103:1989;194-198.
37. Rinne U.K., Sonninen V. Brain catecholamines and their metabolites in parkinsonian patients: treatment with levodopa alone or combined with a decarboxylase inhibitor. Arch. Neurol. 28:1973;107-110.
38. Rubin R.C., Hochwald G.M., Tiell M., Epstein F., Ghatak N., Wisniewski H. Hydrocephalus. III. Reconstitution of the cerebral cortical mantle following ventricular shunting Surg. Neurol. 5:1976;179-183.
39. Schurr P.H., McLaurin R.L., Ingraham F.D. Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in the dog. J. Neurosurg. 10:1953;515-525.
40. Shahar E., Lambert R., Hwang P.A., Hoffman H.J. Obstructive hydrocephalus-induced parkinsonism. I: Decreased basal ganglia regional blood flow Pediatr. Neurol. 4:1988;117-119.
41. Sonberg P.R., Coyle J.T. Scientific approaches to Huntington's disease. CRC Crit. Rev. Clin. Neurobiol. 1:1984;1-44.
42. Tashiro Y., Chakrabortty S., Drake J.M., Hattori T. Progressive loss of glutamic acid decarboxylase, parvalbumin and calbindin D28K immunoreactive neurons in the cerebral cortex and hippocampus of adult rat with experimental hydrocephalus. J. Neurosurg. 86:1997;263-271.
43. Villablanca J.R., Marcus R.J., Olmstead C.E. Effects of caudate nuclei or frontal cortical ablations in cats. I. Neurology and gross behavior Exp. Neurol. 52:1976;389-420.
44. T. Wichmann, M.R. DeLong, Pathophysiology of parkinsonism motor abnormalities, in: H. Narabayashi, T. Nagatsu, N. Yanagisawa, Y. Mizuno (Eds.), Advances in Neurology, vol. 60, Raven Press, New York, 1993, pp. 53-61.
45. Williamson E.C., Pearson H.E., McAllister J.P. II Gliosis and ganglion cell death in the developing cat retina during hydrocephalus and after decompression. Dev. Brain Res. 70:1992;47-52.
46. Wright L.C., McAllister J.P. II, Katz S.D., Miller D.W., Lovely T.J., Salotto A.G., Wolfson B.J. Cytological and cytoarchitectural changes in the feline cerebral cortex during experimental infantile hydrocephalus. Pediatr. Neurosurg. 16:1991;139-155.
47. Yamada H., Yokota A., Furuta A., Horie A. Reconstitution of shunted mantle in experimental hydrocephalus. J. Neurosurg. 76:1992;856-862.